Literature DB >> 23164781

G protein-coupled estrogen receptor: a new therapeutic target in stroke and traumatic brain/spinal cord injury?

Eric R Prossnitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23164781      PMCID： PMC3641187          DOI： 10.1097/CCM.0b013e31826be998

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  20 in total

1.  Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.

Authors:  J W Simpkins; G Rajakumar; Y Q Zhang; C E Simpkins; D Greenwald; C J Yu; N Bodor; A L Day
Journal:  J Neurosurg       Date:  1997-11       Impact factor: 5.115

2.  A transmembrane intracellular estrogen receptor mediates rapid cell signaling.

Authors:  Chetana M Revankar; Daniel F Cimino; Larry A Sklar; Jeffrey B Arterburn; Eric R Prossnitz
Journal:  Science       Date:  2005-02-10       Impact factor: 47.728

3.  Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.

Authors:  Eric Blasko; Christopher A Haskell; Stewart Leung; Giovanna Gualtieri; Meredith Halks-Miller; Mithra Mahmoudi; Megan K Dennis; Eric R Prossnitz; William J Karpus; Richard Horuk
Journal:  J Neuroimmunol       Date:  2009-08-06       Impact factor: 3.478

Review 4.  Methylprednisolone in acute spinal cord injury: a tarnished standard.

Authors:  Sanford M Miller
Journal:  J Neurosurg Anesthesiol       Date:  2008-04       Impact factor: 3.956

5.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

Authors:  E J Filardo; J A Quinn; K I Bland; A R Frackelton
Journal:  Mol Endocrinol       Date:  2000-10

Review 6.  Regulation of signal transduction pathways by estrogen and progesterone.

Authors:  Dean P Edwards
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

Review 7.  The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease.

Authors:  Jenna C Carroll; Emily R Rosario
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

Review 8.  Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn; Harriet O Smith; Tudor I Oprea; Larry A Sklar; Helen J Hathaway
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

9.  Virtual and biomolecular screening converge on a selective agonist for GPR30.

Authors:  Cristian G Bologa; Chetana M Revankar; Susan M Young; Bruce S Edwards; Jeffrey B Arterburn; Alexander S Kiselyov; Matthew A Parker; Sergey E Tkachenko; Nikolay P Savchuck; Larry A Sklar; Tudor I Oprea; Eric R Prossnitz
Journal:  Nat Chem Biol       Date:  2006-03-05       Impact factor: 15.040

10.  Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats.

Authors:  Diane Lebesgue; Michael Traub; Maxine De Butte-Smith; Christopher Chen; R Suzanne Zukin; Martin J Kelly; Anne M Etgen
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240
View more
  8 in total

1.  A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.

Authors:  Chetana M Revankar; Cristian G Bologa; Richard A Pepermans; Geetanjali Sharma; Whitney K Petrie; Sara N Alcon; Angela S Field; Chinnasamy Ramesh; Matthew A Parker; Nikolay P Savchuk; Larry A Sklar; Helen J Hathaway; Jeffrey B Arterburn; Tudor I Oprea; Eric R Prossnitz
Journal:  Cell Chem Biol       Date:  2019-11-06       Impact factor: 8.116

2.  GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.

Authors:  Tapan K Nayak; Chinnasamy Ramesh; Helen J Hathaway; Jeffrey P Norenberg; Jeffrey B Arterburn; Eric R Prossnitz
Journal:  Mol Cancer Res       Date:  2014-07-16       Impact factor: 5.852

Review 3.  GPER modulators: Opportunity Nox on the heels of a class Akt.

Authors:  Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-08       Impact factor: 4.292

Review 4.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 5.  Estrogenic hormones receptors in Alzheimer's disease.

Authors:  Angeles C Tecalco-Cruz; Jesús Zepeda-Cervantes; Bibiana Ortega-Domínguez
Journal:  Mol Biol Rep       Date:  2021-10-16       Impact factor: 2.316

6.  G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.

Authors:  Helen J Hathaway; Eric R Prossnitz; Nicole A Marjon; Chelin Hu
Journal:  Mol Cancer Res       Date:  2014-07-16       Impact factor: 5.852

7.  G-1 exerts neuroprotective effects through G protein-coupled estrogen receptor 1 following spinal cord injury in mice.

Authors:  Qiang Cheng; Jia Meng; Xin-Shang Wang; Wen-Bo Kang; Zhen Tian; Kun Zhang; Gang Liu; Jian-Ning Zhao
Journal:  Biosci Rep       Date:  2016-08-31       Impact factor: 3.840

8.  Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling.

Authors:  Fahmi Mesmar; Bingbing Dai; Ahmed Ibrahim; Linnea Hases; Mohammed Hakim Jafferali; Jithesh Jose Augustine; Sebastian DiLorenzo; Ya'an Kang; Yang Zhao; Jing Wang; Michael Kim; Chin-Yo Lin; Anders Berkenstam; Jason Fleming; Cecilia Williams
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.